Distribution of Epstein‐Barr viral load in serum of individuals from nasopharyngeal carcinoma high‐risk families in Taiwan
暂无分享,去创建一个
Chien-Jen Chen | M. Gulley | A. Goldstein | A. Hildesheim | D. Whitby | Sandra H. Elmore | Yu‐Juen Cheng | S. Diehl | Xiaohong R. Yang | C. Rabkin | Jen‐Yang Chen | W. Hsu | B. Ortiz‐Conde | Mei‐Ying Liu | Brenda Sun | Michael A Walters | Wen Shao | Michael Walters
[1] Chien-Jen Chen,et al. Evaluation of Risk Factors for Nasopharyngeal Carcinoma in High-Risk Nasopharyngeal Carcinoma Families in Taiwan , 2005, Cancer Epidemiology Biomarkers & Prevention.
[2] M. Melbye,et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China , 2005, Cancer.
[3] M. Gulley,et al. Laboratory markers of tumor burden in nasopharyngeal carcinoma: A comparison of viral load and serologic tests for Epstein‐Barr virus , 2004, International journal of cancer.
[4] M. Gulley,et al. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. , 2004, The Journal of molecular diagnostics : JMD.
[5] Raymond W. M. Ng,et al. Quantitative analysis of plasma cell–free Epstein‐Barr virus DNA in nasopharyngeal carcinoma after salvage nasopharyngectomy: A prospective study , 2004, Head & neck.
[6] Chien-Jen Chen,et al. Epstein‐Barr virus seroreactivity among unaffected individuals within high‐risk nasopharyngeal carcinoma families in Taiwan , 2004, International journal of cancer.
[7] Y. Shugart,et al. Familial risk and clustering of nasopharyngeal carcinoma in Guangdong, China , 2004, Cancer.
[8] Yau-Huei Wei,et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. , 2004, The New England journal of medicine.
[9] S. Kondo,et al. Diagnostic value of serum EBV‐DNA quantification and antibody to viral capsid antigen in nasopharyngeal carcinoma patients , 2004, Cancer science.
[10] M. Gulley,et al. Epstein-Barr Virus (EBV) DNA in Plasma Is Not Encapsidated in Patients With EBV-Related Malignancies , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[11] I. Ernberg,et al. Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma , 2004, Cancer.
[12] Ze-feng Xu,et al. [The clinical value of quantitative analysis of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma]. , 2004, Zhonghua er bi yan hou ke za zhi.
[13] S. Leung,et al. Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody. , 2004, Clinical chemistry.
[14] E. Vaccher,et al. Quantitative plasma/serum EBV DNA load by LMP2A determination in an Italian cohort of NPC patients. , 2003, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[15] S. Leung,et al. Molecular characterization of circulating EBV DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. , 2003, Cancer research.
[16] Yi Zeng,et al. Familial nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.
[17] S. Leung,et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. , 2002, Journal of the National Cancer Institute.
[18] C. J. Chen,et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. , 2001, The New England journal of medicine.
[19] C. J. Chen,et al. Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] S. Leung,et al. Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. , 2000, Cancer research.
[21] S. Leung,et al. Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. , 2000, Cancer research.
[22] S. Glaser,et al. Epstein-barr virus-associated malignancies: epidemiologic patterns and etiologic implications. , 2000, Critical reviews in oncology/hematology.
[23] U. Prasad,et al. Analysis and Significance of Anti-Latent Membrane Protein-1 Antibodies in the Sera of Patients with EBV-Associated Diseases , 2000, The Journal of Immunology.
[24] S. Leung,et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. , 1999, Cancer research.
[25] S. Proctor,et al. Detection of Epstein‐Barr virus (EBV) genomes in the serum of patients with EBV‐associated Hodgkin's disease , 1999, International journal of cancer.
[26] S. Leung,et al. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. , 1999, Cancer research.
[27] M. Gulley,et al. Epstein-Barr virus infection is associated with p53 accumulation in nasopharyngeal carcinoma. , 1998, Human pathology.
[28] C. J. Chen,et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. , 1997, Journal of the National Cancer Institute.
[29] J. Morris,et al. Epidemiology and prevention. , 1982, The Milbank Memorial Fund quarterly. Health and society.
[30] E. Lennette,et al. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. , 1993, European journal of cancer.
[31] G. de‐Thé,et al. Differences in EBV antibody titres of patients with nasopharyngeal carcinoma originating from high, intermediate and low incidence areas. , 1978, IARC scientific publications.
[32] W. Henle,et al. Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma , 1976, International journal of cancer.
[33] J. Knowelden,et al. Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.
[34] T. Phillips,et al. Elevated IgA in carcinoma of the nasopharynx , 1975, Cancer.
[35] S. Horiguchi,et al. [Nasopharyngeal cancer]. , 1973, Nihon Jibiinkoka Gakkai kaiho.